279 related articles for article (PubMed ID: 22251483)
1. Delineation of antigen-specific and antigen-nonspecific CD8(+) memory T-cell responses after cytokine-based cancer immunotherapy.
Tietze JK; Wilkins DE; Sckisel GD; Bouchlaka MN; Alderson KL; Weiss JM; Ames E; Bruhn KW; Craft N; Wiltrout RH; Longo DL; Lanier LL; Blazar BR; Redelman D; Murphy WJ
Blood; 2012 Mar; 119(13):3073-83. PubMed ID: 22251483
[TBL] [Abstract][Full Text] [Related]
2. Influenza infection results in local expansion of memory CD8(+) T cells with antigen non-specific phenotype and function.
Sckisel GD; Tietze JK; Zamora AE; Hsiao HH; Priest SO; Wilkins DE; Lanier LL; Blazar BR; Baumgarth N; Murphy WJ
Clin Exp Immunol; 2014 Jan; 175(1):79-91. PubMed ID: 23937663
[TBL] [Abstract][Full Text] [Related]
3. Bystander activation and anti-tumor effects of CD8+ T cells following Interleukin-2 based immunotherapy is independent of CD4+ T cell help.
Monjazeb AM; Tietze JK; Grossenbacher SK; Hsiao HH; Zamora AE; Mirsoian A; Koehn B; Blazar BR; Weiss JM; Wiltrout RH; Sckisel GD; Murphy WJ
PLoS One; 2014; 9(8):e102709. PubMed ID: 25119341
[TBL] [Abstract][Full Text] [Related]
4. Intracellular bacterial vectors that induce CD8(+) T cells with similar cytolytic abilities but disparate memory phenotypes provide contrasting tumor protection.
Stark FC; Sad S; Krishnan L
Cancer Res; 2009 May; 69(10):4327-34. PubMed ID: 19435919
[TBL] [Abstract][Full Text] [Related]
5. IL-21 and IL-15 cytokine DNA augments HSV specific effector and memory CD8+ T cell response.
Rodrigues L; Nandakumar S; Bonorino C; Rouse BT; Kumaraguru U
Mol Immunol; 2009 Apr; 46(7):1494-504. PubMed ID: 19233474
[TBL] [Abstract][Full Text] [Related]
6. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of CT26 murine tumors is characterized by an oligoclonal response of tissue-resident memory T cells against the AH1 rejection antigen.
Stringhini M; Probst P; Neri D
Eur J Immunol; 2020 Oct; 50(10):1591-1597. PubMed ID: 32470143
[TBL] [Abstract][Full Text] [Related]
8.
Wang B; Zhang W; Jankovic V; Golubov J; Poon P; Oswald EM; Gurer C; Wei J; Ramos I; Wu Q; Waite J; Ni M; Adler C; Wei Y; Macdonald L; Rowlands T; Brydges S; Siao J; Poueymirou W; MacDonald D; Yancopoulos GD; Sleeman MA; Murphy AJ; Skokos D
Sci Immunol; 2018 Nov; 3(29):. PubMed ID: 30389797
[TBL] [Abstract][Full Text] [Related]
9. Self-reactive memory-phenotype CD8 T cells exhibit both MHC-restricted and non-MHC-restricted cytotoxicity: a role for the T-cell receptor and natural killer cell receptors.
Dhanji S; Teh SJ; Oble D; Priatel JJ; Teh HS
Blood; 2004 Oct; 104(7):2116-23. PubMed ID: 15178577
[TBL] [Abstract][Full Text] [Related]
10. Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8
Hasan AN; Selvakumar A; Shabrova E; Liu XR; Afridi F; Heller G; Riviere I; Sadelain M; Dupont B; O'Reilly RJ
Clin Exp Immunol; 2016 Nov; 186(2):249-265. PubMed ID: 27227483
[TBL] [Abstract][Full Text] [Related]
11. Enhancing Dendritic Cell-based Immunotherapy with IL-2/Monoclonal Antibody Complexes for Control of Established Tumors.
Kim MT; Richer MJ; Gross BP; Norian LA; Badovinac VP; Harty JT
J Immunol; 2015 Nov; 195(9):4537-44. PubMed ID: 26408669
[TBL] [Abstract][Full Text] [Related]
12. Impaired tumor rejection by memory CD8 T cells in mice with NKG2D dysfunction.
André MC; Sigurdardottir D; Kuttruff S; Pömmerl B; Handgretinger R; Rammensee HG; Steinle A
Int J Cancer; 2012 Oct; 131(7):1601-10. PubMed ID: 21607945
[TBL] [Abstract][Full Text] [Related]
13. The Emerging Role of CD8
Corgnac S; Boutet M; Kfoury M; Naltet C; Mami-Chouaib F
Front Immunol; 2018; 9():1904. PubMed ID: 30158938
[TBL] [Abstract][Full Text] [Related]
14. PD-1 Blockade Unleashes Effector Potential of Both High- and Low-Affinity Tumor-Infiltrating T Cells.
Martínez-Usatorre A; Donda A; Zehn D; Romero P
J Immunol; 2018 Jul; 201(2):792-803. PubMed ID: 29875150
[TBL] [Abstract][Full Text] [Related]
15. IL-7/αIL-7 mAb M25 immunocomplexes expand CD8
Hrabos D; Hnizdilova T; Tomala J; Uhlik J; Kovar M
Cytokine; 2020 Sep; 133():155174. PubMed ID: 32599539
[TBL] [Abstract][Full Text] [Related]
16. IL-15 Trans-Signaling with the Superagonist RLI Promotes Effector/Memory CD8+ T Cell Responses and Enhances Antitumor Activity of PD-1 Antagonists.
Desbois M; Le Vu P; Coutzac C; Marcheteau E; Béal C; Terme M; Gey A; Morisseau S; Teppaz G; Boselli L; Jacques Y; Béchard D; Tartour E; Cassard L; Chaput N
J Immunol; 2016 Jul; 197(1):168-78. PubMed ID: 27217584
[TBL] [Abstract][Full Text] [Related]
17. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.
Contreras A; Sen S; Tatar AJ; Mahvi DA; Meyers JV; Srinand P; Suresh M; Cho CS
Cancer Immunol Immunother; 2016 May; 65(5):601-11. PubMed ID: 27011014
[TBL] [Abstract][Full Text] [Related]
18. Modeling the CD8+ T effector to memory transition in adoptive T-cell antitumor immunotherapy.
Rolle CE; Carrio R; Malek TR
Cancer Res; 2008 Apr; 68(8):2984-92. PubMed ID: 18413768
[TBL] [Abstract][Full Text] [Related]
19. Adoptive Transfer of CD8+ T Cells Generated from Induced Pluripotent Stem Cells Triggers Regressions of Large Tumors Along with Immunological Memory.
Saito H; Okita K; Chang AE; Ito F
Cancer Res; 2016 Jun; 76(12):3473-83. PubMed ID: 27197199
[TBL] [Abstract][Full Text] [Related]
20. Eomes identifies thymic precursors of self-specific memory-phenotype CD8
Miller CH; Klawon DEJ; Zeng S; Lee V; Socci ND; Savage PA
Nat Immunol; 2020 May; 21(5):567-577. PubMed ID: 32284593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
